Journals / Türkiye Acil Tıp Dergisi / 2011 / Cilt: 11 - Sayı: 1

The analysis of cases admitted to ıntensive care units from emergency department due to complications related to warfarin treatment

Varfarin tedavisine bağlı komplikasyonlar nedeniyle acil servisten yoğun bakıma yatırılan olguların analizi

Pages
9–12
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ConclusionsAs a result, besides bleeding, old age, presence of comorbid disease and high INR levels seems to be important factors in the decision of admission to ICU.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ObjectivesMost of cases that present to the emergency departments (EDs) due to complications related to warfarin therapy are successfully treated in the ED, except only for a small group for which admission to the intensive care units (ICUs) is required.
📊
Key Findings & Data:In our study, we aimed to introduce the demographic and clinical characteristics of this group needed to ICU admission.MethodsThe records of 30 patients who presented to the Gulhane Military Medical Academy ED (Ankara, Turkey) and required admission to ICU due to the complications related to warfarin therapy were retrospectively reviewed.
💡
Conclusion & Impact:ConclusionsAs a result, besides bleeding, old age, presence of comorbid disease and high INR levels seems to be important factors in the decision of admission to ICU.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ObjectivesMost of cases that present to the emergency departments (EDs) due to complications related to warfarin therapy are successfully treated in the ED, except only for a small group for which admission to the intensive care units (ICUs) is required. In our study, we aimed to introduce the demographic and clinical characteristics of this group needed to ICU admission.MethodsThe records of 30 patients who presented to the Gulhane Military Medical Academy ED (Ankara, Turkey) and required admission to ICU due to the complications related to warfarin therapy were retrospectively reviewed. Patients were evaluated according to age, sex, bleeding region, comorbid diseases, INR (International Normalized Ratio) levels, treatments and outcomes. ResultsAverage age of patients were 66.9±12 and 57% of the patients were female. Eighty percent of the patients (n=24) had 2 or more comorbid disease. Average INR level have been determined as 9.46. INR levels were under 5 in 11 patients (16.6%), between 5-9 in 15 patients (36.6%) and between 9-18 in 14 patients (46.6%). The most common observed bleeding region was in gastrointestinal system with 13 patients (43%) followed by genitourinary system with 8 patients (26%). Intravenous vitamin K therapy in 25 patients (83%), FFP (fresh frozen plasma) therapy in 23 patients (76%) and erythrocyte suspension therapy in 13 patients (43%) have been provided. Mortality was observed in two patients (6.6%) and these patients’ INR levels were 7.92 and 7.15, respectively. The gastrointestinal and genitourinary systems are most frequently seen bleeding sites. Vitamin K and FFP application were required for significant proportion of the patients who are admitted to ICU. No significant relationship between INR levels and mortality has been observed. ConclusionsAs a result, besides bleeding, old age, presence of comorbid disease and high INR levels seems to be important factors in the decision of admission to ICU.

Özet

AmaçVarfarin tedavisine bağlı komplikasyonlar nedeniyle başvuran olguların pek çoğu acil serviste başarı ile tedavi edilmekte, sadece küçük bir grupta yoğun bakıma yatış gerekli olmaktadır. Çalışmamızda yoğun bakıma yatışı gereken bu grubun demografik ve klinik özelliklerini ortaya koymayı amaçladık. Gereç ve YöntemAcil servisimize başvuran varfarin tedavisine bağlı komplikasyonlar nedeniyle yoğun bakıma yatışı gerekli görülen 30 hastanın kayıtları retrospektif olarak incelendi. Hastalar yaş, cinsiyet, kanama bölgesi, komorbid hastalıklar, International Normalized Ratio (INR) düzeyleri, uygulanan tedaviler ve sonuçlar açısından değerlendirildi.BulgularHastaların yaş ortalaması 66.9±12 idi; %57’si kadındı. Hastaların %80’i (n=24) 2 ve üstünde komorbid hastalığı mevcuttu. Ortalama INR düzeyi 9.46 olarak saptandı. INR düzeyi 5 hastada (%16.6) 5’in altında, 11 hastada (%36.6) 5-9 arasında, 14 hastada (%46.6) ise INR düzeyi 9-18 arasında saptandı. Kanama bölgesi en sık olarak 13 hastada (%43) gastrointestinal sistemde, 8 hastada (%26) genitoüriner sistemde gözlendi. Hastaların 25’ine (%83) intravenöz K vitamini, 23’üne (%76) TDP (taze donmuş plazma), 13’üne (%43) eritrosit süspansiyonu tedavisi uygulanmıştı. İki olgunun ölümcül seyrettiği (%6.6) gözlendi, bu olguların sırasıyla INR değerleri 7.92 ve 7.15 idi. En sık gastrointestinal ve genitoüriner sistem kanamaları görülmektedir. Yoğun bakıma yatışı yapılan hastaların önemli bir kısmında K vitamini ve TDP kullanımına ihtiyaç duyulmuştur. INR düzeyleri ve mortalite arasında belirgin bir ilişki gözlenmemiştir.SonuçSonuç olarak, kanamanın yanında ileri yaş, komorbid hastalık ve yüksek INR düzeyleri de yoğun bakıma yatış kararı üzerinde etkili faktörler gibi görünmektedir.

🔖

Cite This Article

İNAL, V., ÇINAR, O., CÖMERT, B., EROĞLU, M., DURUSU, M., YAMANEL, L., ÇEVİK, E. (2022). The analysis of cases admitted to ıntensive care units from emergency department due to complications related to warfarin treatment. Türkiye Acil Tıp Dergisi, Cilt: 11 - Sayı: 1, 9–12. https://ajindex.com/articles/626003

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hamby L, Weeks WB, Malikowski C. Complications of Warfarin Therapy: Causes, Costs, and the Role of the Anticoagulation Clinic. Eff Clin Prac 2000;4:179-84
  2. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The Pharmacology and Management of the Vitamin K Antagonists. Chest 2004;126:204-33
  3. Horton JD, Bushwick BM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician 1999;59:635-46
  4. Copland M, Walker ID, Tait RC. Oral Anticoagulation and Hemorrhagic Complications in an Elderly Population With Atrial Fibrillation. Arch Intern Med 2001;161:2125-28
  5. Gullov AL, Koefoed BG, Petersen P. Bleeding During Warfarin and Aspirin Therapy in Patients With Atrial Fibrillation. Arch Intern Med 1999;159:1322-8
  6. Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991;324:1865-75
  7. Hylek ME, Singer DE. Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin. Ann Intern Med 1994;120:897-902
  8. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006;4:1853-63
  9. Denizbaşı A, Ünlüer EE, Güneysel O, Eroğlu S, Koşargelir M. Complications of warfarin therapy and the correlation of the outcomes with international normalized ratio levels. Eur J Emerg Med 2006;13:47-8
  10. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic Complications of Anticoagulant Treatment. Chest 2004;126:287-310
  11. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D’Angelo A ve ark. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348:423-8
  12. Makris M, Watson HG. The management of coumarin-induced over-anticoagulation. Br J Haematol 2001;114:271-80
  13. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin. Ann Intern Med 1996;124:970-9
  14. MacMahan DA, Smith DM, Carey MA, Zhou XH. Risk of Major Hemorrhage for Outpatients Treated with Warfarin. J Gen Intern Med 1998;13:311-6
  15. Van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993;153:1557-62
  16. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency Oral Anticoagulant Reversal: The Relative Efficacy of Infusions of Fresh Frozen Plasma and Clotting Fact